MEDICAL ADVOCATES
 IDUs
  HIV Management Therapeutic
Challenges/Strategies

General Reports
ARV Injection Drug Interactions
Substance Use During ARV Therapy
 Starting Therapy   
Directly Observed Therapy              
Prevention
 
HIV Management Main Page Main New/Newsworthy  Home Page
Last Update:  June 03, 2017   
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
       
         Journal Papers, Abstracts, and Commentaries
 
Cognitive Behavioral Therapy for Adherence and Depression (CBT-AD) in HIV-Infected Injection Drug Users:
A Randomized Controlled Trial.
Safren SA, O'Cleirigh CM, Bullis JR,  et al
J Consult Clin Psychol. 2012 Apr 30.  
 Abstract

A WEEK-IN-REVIEW FEATURED REPORT
Retention in Opioid Substitution Treatment: A Major Predictor of Long-Term Virological
Success or HIV-Infected Injection Drug Users Receiving Antiretroviral Treatment.
Roux P, Carrieri MP, Cohen J, Ravaux I, et al
Clin Infect Dis. 2009 Oct 6.
Abstract
ARV/Injection Drug Interactions
       
         Journal Papers, Abstracts, and Commentaries
 
  Drug interactions between opioids and antiretroviral medications: interaction between
methadone, LAAM, and nelfinavir.
McCance-Katz EF, Rainey PM
 Am J Addict. 2004 Mar-Apr;13(2):163-80.
 Abstract
 
Opioid/ARV Interactions
       
         Journal Papers, Abstracts, and Commentaries
 
  Drug interactions between opioids and antiretroviral medications: interaction between
methadone, LAAM, and nelfinavir.
McCance-Katz EF, Rainey PM
 Am J Addict. 2004 Mar-Apr;13(2):163-80.
 Abstract
Substance Use Use During HAART
       

         Journal Papers, Abstracts, and Commentaries

  Impaired Virologic Response to Highly Active Antiretroviral Therapy Associated
With Ongoing Injection Drug Use.
Palepu A, Tyndall M, Yip B, et al.   
J Acquir Immune Defic Syndr 2003 Apr 15;32(5):522-526
 Abstract		  
Starting Treatment
       

         Journal Papers, Abstracts, and Commentaries

  Time to initiating highly active antiretroviral therapy among HIV-infected injection
drug users.
Celentano DD, Galai N, Sethi AK, et al.  
AIDS 2001 Sep 7;15(13):1707-15
 Abstract
Directly Observed Therapy (DOT)
       

              Journal Papers, Abstracts, and Commentaries

 
Medication Persistence of HIV-infected Drug Users on Directly Administered Antiretroviral Therapy.
Ing EC, Bae JW, Maru DS, Altice FL.
AIDS Behav. 2011 Nov 22.
 Abstract

Directly observed antiretroviral therapy improves adherence and viral load in drug users
attending methadone maintenance clinics: A randomized controlled trial.
Berg KM, Litwin A, Li X,  et al
Drug Alcohol Depend. 2010 Sep 8
 Abstract

Rationale, design, and sample characteristics of a randomized controlled trial of directly observed
antiretroviral therapy delivered in methadone clinics.
Berg KM, Mouriz J, Li X, , et al
Contemp Clin Trials. 2009 Jun 6.
Abstract

Directly Administered Antiretroviral Therapy in Methadone Clinics Is Associated with
Improved HIV Treatment Outcomes, Compared with Outcomes among Concurrent
Comparison Groups.
Lucas GM, Mullen BA, Weidle PJ, et al 
Clin Infect Dis. 2006 Jun 1;42(11):1628-35.
 Abstract
 
Developing a directly administered antiretroviral therapy intervention for HIV-infected
drug users: implications for program replication.
Altice FL, Mezger JA, Hodges J,et al
Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S376-87
 Abstract
 
Directly observed therapy for the management of HIV-infected patients in a
methadone program.
 Conway B, Prasad J, Reynolds R, et al
Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S402-8.
 Abstract
 
Directly administered antiretroviral therapy in an urban methadone maintenance
clinic: a nonrandomized comparative study.
Lucas GM, Weidle PJ, Hader S, Moore RD.
Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S409-13
 Abstract
 
Modified directly observed therapy for the treatment of HIV-seropositive substance users:
lessons learned from a pilot study.
Macalino GE, Mitty JA, Bazerman LB, et al
 Clin Infect Dis. 2004 Jun 1;38
Abstract
 
Modified directly observed therapy (MDOT) for injection drug users with HIV disease.
McCance-Katz EF, Gourevitch MN, Arnsten J, et al
Am J Addict. 2002 Fall;11(4):271-8.
Abstract

Directly observed antiretroviral therapy for injection drug users with HIV infection.
Clarke S, Keenan E, Ryan M, Barry M, Mulcahy F.
AIDS Read 2002 Jul;12(7):305-7, 312-6
 Abstract
 

  
Prevention
       
         Journal Papers, Abstracts, and Commentaries
 
Immunologic and Virologic Mechanisms for Partial Protection from Intravenous Challenge by an Integration-Defective SIV Vaccine.
Wang C, Jiang C, Gao N,   |
Viruses. 2017 Jun 2;9(6).
Abstract

Reducing non-injection drug use in HIV primary care: A randomized trial of brief motivational interviewing, with and without HealthCall, a technology-based enhancement.
Aharonovich E, Sarvet A, Stohl M,  
J Subst Abuse Treat. 2017 Mar;74:71-79.
 

Prevalence and Correlates of the Use of Prefilled Syringes Among Persons Who Inject Drugs in San Diego, CA.
Armenta RF, Roth AM, Wagner KD,  et al
J Urban Health. 2015 Sep 17
 Abstract

Can HIV and HCV Infection be Eliminated among Persons who Inject Drugs?
Perlman DC, Des Jarlais DC, Feelemyer J.
J Addict Dis. 2015 Jun 15:
 Abstract

Preexposure Prophylaxis Reduces HIV Risk in Injection-Drug Users.
Rosenberg K.
Am J Nurs. 2013 Sep;113(9):17.
 Abstract

 
HIV Management Main Page Main New/Newsworthy  Home Page

IDU Health: HIV Clinical Management